In hematological malignancies, NM23 genes are over expressed in acute myelogenous leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myelogenous leukemia in blastic crisis (CMLBC), and myelodysplastic syndrome (MDS). This evidence concerns the gene NME1 and acute myeloid leukemia.